Docoh
Loading...

Tue. 23 Feb 2021, 4:45am ETBenzinga
In: News, Price Target, Analyst Ratings
SVB Leerink analyst Richard Newitter maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $23 to $27.